Catalio Capital Management, LP
Position in ADPT — Adaptive Biotechnologies Corp
CIK 1958125
NEW YORK, NY
Position in ADPT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,032,241
-$3,303,965 QoQ
Shares Held
722,784
-12.0% QoQ
Ownership
0.452%
of shares outstanding
% of Portfolio
2.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Catalio Capital Management, LP holds $24,212,931 across 2 Diagnostics & Research names. ADPT ranks #2 (41.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
70,907 | $14,180,690 | |
| 2 | ADPT |
Adaptive Biotechnologies Corp
This page
|
722,784 | $10,032,241 |
All Filings in ADPT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,032,241 | 722,784 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,336,206 | 821,195 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $13,237,954 | 884,890 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $16,268,584 | 1,396,445 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,544,477 | 611,639 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||